Phase III results show brexpiprazole to be well tolerated as adjunctive therapy for MDD patients March 7, 2014
Longer-acting clotting factor FVIIa-CTP shows promise, obtains FDA orphan drug designation March 5, 2014
Northern Manhattan Study links markers of infection and neuroendocrine dysfunction with stroke risk March 5, 2014
Pharmacosmos presents data on iron isomaltoside 1000 for the treatment of iron deficiency and IBD March 4, 2014
RSS